Stock: Quest Diagnostics (US broad), ISIN: US74834L1008

Last Price 124.97 Max Price 130.01
Min Price 73.34 1 Year return 17.02

Quest Diagnostics

(US74834L1008)/ DGX

The past year was a profitable year Quest Diagnostics investors

The stock gained over the past 12 months at around 34 percent. Quest Diagnostics' stock rose the past 5 years at around 60 percent. Quest Diagnostics's revenues between 2011 and 2015 were quite stable and moved between 7,38 billion dollars and 7,49 billion dollars. During 2011 and 2015 Quest Diagnostics's net results were very volatile and fluctuated between 507,23 million dollars and 753 million dollars.

Quest Diagnostics is mostly active in the health care eq. & services sector. The global health care companies gained over the past 10 years on average 102 percent. Since 2011 the sector is 64 percent higher and over the past year plus 102 percent.

The American company paid out dividends in the past 5 years. On average Quest Diagnostics's dividend yield over the past 5 years was around 5,29 percent annually.

Quest Diagnostics' balance mostly consists of equity

As per the end of 2015 the American company's balance sheet equaled 9,96 billion dollars. At the end of 2015 the total debt positon equaled 5,28 billion dollars. This is around 52,98 percent of the total balance sheet. At the end of 2015 the health care company's stock was traded with a price/earnings-ratio 19. So the stock' value was 19 times the 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the health care company equaled around 10,04 billion dollars. At the end of 2015 around 143 million stocks were listed.

All Quest Diagnostics's financial reports are located here. More information about Quest Diagnostics can be found it's website. .